Labcorp Holdings Inc (BSP:L1CA34)
R$ 309.8 0 (0%) Market Cap: 103.65 Bil Enterprise Value: 139.66 Bil PE Ratio: 44.11 PB Ratio: 2.33 GF Score: 78/100

Laboratory Corporation of America Holdings at UBS Global Healthcare Virtual Conference Transcript

May 24, 2021 / 07:00PM GMT
Release Date Price: R$362 (+1.69%)
Kevin Caliendo
UBS Investment Bank, Research Division - Equity Research Analyst of Healthcare IT and Distribution

Hi, everyone, I'm Kevin Caliendo, Healthcare Services Analyst at UBS. This afternoon, I am very proud to have with us Adam Schechter, CEO; and Glenn Eisenberg, CFO of LabCorp. Gentlemen, thank you so much for joining us today.

Adam H. Schechter
Laboratory Corporation of America Holdings - President, CEO & Chairman

Yes, it's a pleasure to see you, and we're glad to be here.

Kevin Caliendo
UBS Investment Bank, Research Division - Equity Research Analyst of Healthcare IT and Distribution

It's really good to see you, guys, and nice to see everybody in the same room with no masks on. And hopefully, everyone down there is healthy and well.

I wanted to start off maybe a little bit different than normal. I've heard you speak a couple of times recently and you talked about how you think your stock is undervalued.

And quite frankly, I think your stock is undervalued as well. But to prove

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot